Biocryst Pharmaceuticals buy Royal Bank of Canada
Start price
11.04.25
/
50%
€5.91
Target price
11.04.26
€9.75
Performance (%)
29.04%
Price
14:23
€7.63
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada currently has a performance of 29.04%. This prediction currently runs until 11.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biocryst Pharmaceuticals | -8.223% | -8.223% |
| iShares Core DAX® | 1.263% | -1.123% |
| iShares Nasdaq 100 | 0.531% | 2.176% |
| iShares Nikkei 225® | 1.532% | 1.686% |
| iShares S&P 500 | 0.904% | 1.784% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $11.00 price target on the stock.
Ratings data for BCRX provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Biocryst Pharmaceuticals
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.60
30.06.25
30.06.25
€11.09
30.06.26
30.06.26
-0.34%
14:23
14:23
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€8.90
06.05.25
06.05.25
€11.51
06.05.26
06.05.26
-14.86%
14:23
14:23
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€7.79
25.02.25
25.02.25
€10.47
25.02.26
25.02.26
-2.72%
14:23
14:23
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.61
05.11.24
05.11.24
€9.16
05.11.25
05.11.25
14.61%
14:23
14:23
Biocryst Pharmaceuticals
Start price
Target price
Perf. (%)
€6.95
25.09.23
25.09.23
€9.44
25.09.24
25.09.24
-2.42%
26.09.24
26.09.24